Northwestern Mutual Wealth Management
FOLD

Northwestern Mutual Wealth Management’s Amicus Therapeutics FOLD Stock Holding History

Northwestern Mutual Wealth Management’s Portfolio FOLD Stock Details FOLD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-350
Closed -$5.06K – 4227
2026
Q1 		$5.06K Sell
350
-1,162
-77% -$16.7K ﹤0.01% 3310
2025
Q4 		$21.5K Buy
1,512
+1,162
+332% +$11.4K ﹤0.01% 2719
2025
Q3 		$2.76K Hold
350
– – ﹤0.01% 3310
2025
Q2 		$2.01K Sell
350
-129
-27% -$833 ﹤0.01% 3259
2025
Q1 		$3.91K Buy
479
+25
+6% +$231 ﹤0.01% 3007
2024
Q4 		$4.28K Buy
454
+104
+30% +$1.08K ﹤0.01% 2990
2024
Q3 		$3.74K Hold
350
– – ﹤0.01% 2981
2024
Q2 		$3.47K Hold
350
– – ﹤0.01% 2973
2024
Q1 		$4.12K Hold
350
– – ﹤0.01% 2896
2023
Q4 		$4.97K Hold
350
– – ﹤0.01% 2862
2023
Q3 		$4.26K Hold
350
– – ﹤0.01% 2796
2023
Q2 		$4.4K Buy
+350
New +$4.15K ﹤0.01% 2821
2023
Q1 		– Sell
-20
Closed -$244 – 3445
2022
Q4 		$244 Buy
+20
New +$225 ﹤0.01% 3174
2022
Q2 		– Sell
-12
Closed – – 3272
2022
Q1 		$0 Buy
+12
New +$113 ﹤0.01% 3205

Other funds holding FOLD

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $20.6B AUM 34.61% 1-Year Est. Return

Northwestern Mutual Wealth Management's FOLD Position: Q2 2026 in Review

Northwestern Mutual Wealth Management sold out of Amicus Therapeutics (FOLD) in Q2 2026, closing a stake of 350 shares — an estimated $5.06K sold.

Northwestern Mutual Wealth Management first reported a position in FOLD in Q1 2022 and held it in 14 quarters. The position peaked at $21.5K in Q4 2025. 2 funds tracked by Wall St. Rank hold FOLD as of Q2 2026.

  • Northwestern Mutual Wealth Management reported no remaining Amicus Therapeutics position as of Q2 2026 after selling out during the quarter.
  • Northwestern Mutual Wealth Management sold 350 Amicus Therapeutics shares in Q2 2026, an estimated $5.06K.
  • Northwestern Mutual Wealth Management first reported a position in Amicus Therapeutics in Q1 2022 and held it in 14 quarters.
  • Northwestern Mutual Wealth Management's Amicus Therapeutics position peaked at $21.5K in Q4 2025.
  • 2 funds tracked by Wall St. Rank held Amicus Therapeutics as of Q2 2026.

Based on Northwestern Mutual Wealth Management's 13F filing for Q2 2026, filed 12 Aug 2026.